All Stories

  1. Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update
  2. Necrotizing soft-tissue infections survival guide in adult patients: A position statement by the Global Alliance for Infections in Surgery
  3. Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update
  4. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
  5. Implementation of a pilot program of interprofessional education in infection prevention
  6. The New Reality of Infective Endocarditis: Changes in Patient Demographics and Outcomes in South Carolina
  7. Association Between Reporting Antimicrobial Use and Clostridioides difficile Standardized Infection Ratios in South Carolina Hospitals
  8. Appropriateness of ambulatory antibiotic prescribing in South Carolina, 2012–2017
  9. Oral switch antibiotic therapy in uncomplicated Enterococcus faecalis bloodstream infection
  10. Missed Opportunities for Early De-Escalation of Antipseudomonal Beta-Lactam Antimicrobial Therapy in Enterobacterales Bloodstream Infection
  11. WHO global research priorities for antimicrobial resistance in human health
  12. Incidence and predictors of complications in Gram-negative bloodstream infection
  13. Evaluation of the diagnostic utility of metagenomic next-generation sequencing testing for pathogen identification in infected hosts: a retrospective cohort study
  14. The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States
  15. 750. Launching the South Carolina Regional Infection Prevention Training (SCRIPT) Center: A Pilot in Interprofessional Education
  16. 2763. Evaluating the Safety and Effectiveness of Long-term Antibiotic Suppression in Patients with Left Ventricular Assist Devices
  17. 2399. Changing Demographics of Infective Endocarditis in South Carolina: An Ecological Study
  18. Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute Pyelonephritis
  19. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action
  20. Interventions in the management of diabetes‐related foot infections: A systematic review
  21. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023)
  22. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)
  23. Diagnosis of infection in the foot of patients with diabetes: A systematic review
  24. Intravenous versus Partial Oral Antibiotic Therapy in the Treatment of Uncomplicated Bloodstream Infection Due to Streptococcus Species
  25. Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
  26. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation
  27. Ecologic analysis of antimicrobial use in South Carolina hospitals during 2020–2022
  28. Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
  29. Paradoxical outcomes of gram‐negative bloodstream infection in solid organ transplant recipients
  30. The progression of sepsis from physiologic systemic inflammatory response to immune dysregulation due to life-threatening infections
  31. Weighing the odds of Bloodstream Infection. What is the Perfect Model to Predict this Risk?
  32. Temporal Association between Influenza Vaccination Coverage and Ambulatory Antibiotic Use in Children
  33. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey
  34. Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection
  35. Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs)
  36. Candida parapsilosis bloodstream infection in an immunocompromised host with discordant multiplex polymerase chain reaction and conventional blood culture results: a case report
  37. Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care
  38. Prediction of Mortality in Staphylococcus aureus Bloodstream Infection using Quick Pitt Bacteremia Score
  39. 44. Cost Effectiveness and Clinical Outcomes of Long Acting Lipoglycopeptides Used in Transitions of Care for Deep-Seated Infections
  40. 1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
  41. 1388. Epidemiology and Treatment Outcomes of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
  42. Change in Antimicrobial Use during COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study
  43. A pandemic recap: lessons we have learned
  44. Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection
  45. Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System
  46. Novel method of calculating adjusted antibiotic use by microbiological burden
  47. Risk and Clinical Outcomes of Acute Myocardial Infarction and Acute Ischemic Stroke following Gram-Negative Bloodstream Infection
  48. Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy
  49. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap
  50. Motivational Application of Standardized Antimicrobial Administration Ratios Within a Healthcare System
  51. 243. Temporal Trends in Appropriateness of Ambulatory Antibiotic Prescribing in South Carolina
  52. 290. Impact of follow up blood cultures on outcomes of patients with gram-negative bloodstream infections
  53. 313. Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant Enterobacterales Bloodstream Infections
  54. 955. Addressing Gaps and Disparities in HIV testing in the Emergency Department
  55. Regulatory Approval, Implementation, and Brief Assessment of a Pharmacist- and Pharmacy Trainee-Administered Penicillin Allergy Assessment and Skin Testing Program
  56. Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients?
  57. Regional and statewide antibiograms as targeted interventions against antibiotic resistance
  58. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location
  59. Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species
  60. Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department
  61. Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
  62. Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Moving Target
  63. RISK OF ACUTE MYOCARDIAL INFARCTIONS AND ACUTE ISCHEMIC STROKES FOLLOWING GRAM-NEGATIVE BLOODSTREAM INFECTIONS
  64. Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system
  65. Empirical Fluoroquinolones versus Broad-Spectrum Beta-Lactams for Gram-Negative Bloodstream Infections in the Absence of Antimicrobial Resistance Risk Factors
  66. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study
  67. Prediction of Sulfamethoxazole/Trimethoprim Resistance in Community-Onset Urinary Tract Infections
  68. Erratum
  69. 2733. Association Between Influenza Vaccination Coverage and Ambulatory Antibiotic Prescription Rates in Children in South Carolina
  70. 122. Evaluation of Early Clinical Failure Criteria in Patients with Enterococcus Species Bloodstream Infection
  71. 851. Validation of Quick Pitt Bacteremia Score in Patients with Staphylococcus aureus Bloodstream Infection
  72. Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
  73. COPD Exacerbations — A Target for Antibiotic Stewardship
  74. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates
  75. Resilience of the Pitt Bacteremia Score: Three Decades and Counting
  76. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents
  77. Oral antibiotics for uncomplicated and complicated bloodstream infections
  78. Evaluation of early clinical failure criteria for gram-negative bloodstream infections
  79. A Baker’s Dozen of Top Antimicrobial Stewardship Publications in 2016
  80. Association Between Body Mass Index and Mortality in Patients With Gram-Negative Bloodstream Infections
  81. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection
  82. Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals
  83. 645
  84. Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy
  85. 475. Burden of Clostridium difficile Infection in South Carolina: A Population-Based Study
  86. 1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
  87. 975. Clostridium difficile Infection and Antibiotic Prescription Rates in the Community: Explaining the Gender Gap
  88. Early de-escalation of antimicrobial therapy reduces risk of C. difficile infection
  89. Minimum Acceptable Susceptibility of Empirical Antibiotic Regimens for Gram-Negative Bloodstream Infections
  90. Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria?
  91. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case–case–control study
  92. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection
  93. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions
  94. Got penicillin allergy? Carbapenems are not the answer
  95. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway
  96. Combination antimicrobial therapy for gram-negative bloodstream infections?
  97. Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
  98. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship—results from an international cross-sectional survey
  99. Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence
  100. The Magic Formula: Optimizing Care While Using Less Broad-Spectrum Antibiotics
  101. For Bloodstream Infections: Optimize, Do Not Minimize
  102. Prediction of fluoroquinolone resistance in patients with complicated urinary tract infections
  103. When to use empirical anti-pseudomonal therapy?
  104. Microbiologic Predictors of Pelvic Osteomyelitis Related to Decubitus Ulcers
  105. Microbiology of Vertebral Osteomyelitis and Implications on Empiric Therapy
  106. A Simplified Pitt Bacteremia Score (qPitt) to Predict Mortality in Patients with Gram-negative Bloodstream Infection
  107. The ESBL Prediction Score
  108. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters – the role of sickle cell anaemia
  109. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae
  110. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections
  111. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis
  112. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
  113. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli
  114. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections
  115. Validation of Fluoroquinolone Resistance Score in Patients With Complicated Urinary Tract Infections
  116. Optimal Duration of Antimicrobial Therapy for Bloodstream Infections Due to Gram-Negative Bacilli
  117. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization
  118. Osteomyelitis After Open Fractures Adjusting Prophylactic Antimicrobial Therapy
  119. Effectiveness of Oral Antibiotics for Definitive Therapy of Gram-Negative Bloodstream Infections
  120. Prediction of Fluoroquinolone Resistance in Patients With Gram-Negative Bloodstream Infection
  121. Combination Versus Monotherapy for Gram-Negative Bloodstream Infections: Matching by Predicted Prognosis
  122. Association Between Inappropriate Empirical Antimicrobial Therapy and Hospital Length of Stay in Gram-Negative Bloodstream Infections
  123. Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle for Local Management of Gram-Negative Bloodstream Infections
  124. Bloodstream Infections and Central Line–Associated Bloodstream Infections
  125. Antibiotics save lives
  126. External validation of bloodstream infection mortality risk score in a population-based cohort
  127. 715Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
  128. 225Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence
  129. 1705Non-Tuberculous Mycobacterial Bloodstream Infections in Patients with In-Dwelling Vascular Access Catheters- Role of Sickle Cell Disease
  130. Community-acquired Methicillin-resistant Staphylococcus aureus Prostatic Abscesses
  131. Predictive scoring model of mortality in Gram-negative bloodstream infection
  132. Asthma and risk of non-respiratory tract infection: a population-based case–control study
  133. Temporal Trends, Clinical Characteristics, and Outcomes of Histoplasmosis in a Tertiary Care Center in Kentucky, 2000 to 2009
  134. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe
  135. Asthma and Risk of Community-Acquired Blood Stream Infection Caused by Escherichia Coli: A Population-Based Case-Control Study
  136. Asthma and Severity of Blood Stream Infection Caused by Escherichia coli: A Population-Based Study
  137. Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study
  138. Impact of Gram-Negative Bloodstream Infection on Long-Term Allograft Survival After Kidney Transplantation
  139. Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998–2007
  140. Cefepime effectiveness in Gram-negative bloodstream infections
  141. Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection
  142. Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study
  143. Recurrent gram-negative bloodstream infection: A 10-year population-based cohort study
  144. Bacteremia complicating gram-negative urinary tract infections: A population-based study
  145. Epidemiology and Outcome of Klebsiella Species Bloodstream Infection: A Population-Based Study
  146. Are E. coli infections more common in the summer?
  147. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007
  148. Incidence Rate and Outcome of Gram-Negative Bloodstream Infection in Solid Organ Transplant Recipients
  149. β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli
  150. Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based Study
  151. Invasive Enteric Infections in Hospitalized Patients With Underlying Strongyloidiasis